| Event Description/Learning Objectives: |
Course Descripotion:
Pharmacogenomics (PGx) is the practice of using information about an individual’s genetic makeup, or genome, to select medications that are likely to be most effective and result in the fewest number of side effects. Michigan Medicine is an authoritative source on PGx scientifically, and also has conducted the world’s largest RCT (n = 1167) on use of PGx in routine clinical practice for the treatment of depression, the most prevalent and disabling psychiatric disorder. This course will introduce clinicians to the purpose and use of psychiatric PGx in order to enhance professional development and clinical performance, as well as to improve patient safety and outcomes. Upon conclusion of the course, clinicians will be able to: 1) describe basic PGx concepts; 2) distinguish which gene-drug relationships have the most evidence supporting their implementation in the clinic; 3) identify which PGx tests to order; and 4) confidently formulate medication plans using PGx test results'
Learning Objectives:
At the end of this activity, participant should be able to:
-
Describe basic pharmacogenomics concepts.
-
Distinguish which gene-drug relationships have the most evidence supporting their implementation in the clinic.
-
Identify which psychiatric pharmacogenomics tests to order.
-
Confidently formulate medication treatment plans using pharmacogenomics test results.
Registration Fee: Only $50 ($10 for residents), thanks to a subsidy received from the U-M Office of
Continuing Medical Education and Lifelong Learning.
Flyer
|